By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The major factors for the growth of the European diagnostic imaging equipment market include the increase in the geriatric population and the rising prevalence of chronic diseases, technological advancement in imaging modalities, and the rising adoption of medical imaging devices.
Changing demographics and an aging population are leading to a significant increase of chronic diseases and with it needed treatments. Especially in early-detection of diseases, radiology plays a central role. As consumers are becoming more aware of their own health and more demanding in the choice of treatment, the markets for diagnostic imaging and healthcare providers as a whole are growing significantly.
The usage of MRI is steadily growing, for instance, personalized care is evolving as an integral part of medicine where molecular imaging is increasing its contribution significantly through the use of non-invasive processes for accurate diagnosis and determination of diseases.
The presence of key market players, as well as other research-intensive and innovative companies in the country with huge funding for research and development activities that are involved in enhancing the MRI technology, are also expected to contribute significantly to the growth of the MRI market in Germany with the launch of advanced and cost-effective systems.
The government-financed systems of Switzerland, Italy, Spain and France cover all PET presentations, but in Germany, PET is nationally reimbursed exclusively for pulmonary tumors for other manifestations, patients must either carry some form of private insurance to cover these expenses or cover the costs themselves. Thus, the absence of a uniform reimbursement policy in Europe will hamper market growth.
Minimally invasive surgeries include reduced post-operative pain, superior cosmetic results, and quicker recovery period. Recently developed medical imaging devices such as CT scan and MRI are extensively utilized in minimally invasive surgeries that proves beneficial for the industry growth.
Hospitals and diagnostic centers are some prime end-user segments of the Europe medical imaging market. Hospitals are projected to exhibit singular expansion, driven by the availability of advanced healthcare facilities that comprise various imaging processes and modalities to image the human anatomy for diagnostic and treatment purposes.
Medical imaging refers to the techniques and processes used to make images of the human body (or parts of it) for a variety of clinical applications, including medical operations and diagnosis, as well as medical science, which includes the study of normal anatomy and function.
It is a subset of biological imaging that includes radiography, endoscopy, thermography, medical photography, and microscopy in a broader sense. Measurement and recording techniques such as electroencephalography (EEG) and magnetoencephalography (MEG) are examples of medical imaging since they create data that can be represented as maps rather than images.
The diagnostic imaging market encompasses a wide range of medical devices and systems used for visualizing the internal structures and functions of the human body, aiding in the diagnosis, and monitoring of various medical conditions. This market’s products include X-ray machines, MRI (Magnetic Resonance Imaging) scanners, CT (Computed Tomography) scanners, ultrasound systems, nuclear medicine equipment, and others.
Offering a variety of portable imaging systems that enable imaging solutions to be brought closer to the patient, Europe is a market leader in providing medical imaging solutions across all modalities.
Cancer and cardiovascular diseases, technological advancements, the creation of medical imaging reagents, and high unmet need for diagnostic imaging procedures are some of the factors that are driving the Europe medical imaging reagents market.
For instance, cardiovascular diseases are one of the leading causes of death Europely. Furthermore, the growing geriatric population is anticipated to increase demand for medical imaging reagents because older people are more likely to suffer chronic diseases.
The Europe Medical Imaging market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Artificial Intelligence (AI) Dominates the Scene
Precision Medicine Takes Center Stage
Minimally Invasive Procedures on the Rise
Point-of-Care Imaging Gaining Momentum
Siemens Healthineers Biograph Vision PET/CT System: This game-changer boasts AI-powered image reconstruction for sharper resolution and reduced radiation dose, ushering in a new era of precision diagnosis for cancer and other diseases.
Philips Healthcare Vereos PET/CT System: This high-performance system touts integrated digital photon counting technology for enhanced image detail and faster scan times, improving patient comfort and workflow efficiency.
GE Healthcare Vivid R95 Ultrasound System: This versatile system features AI-powered automation tools and advanced imaging capabilities, empowering clinicians with real-time insights for a wide range of cardiovascular and abdominal applications.
Canon Medical Alphenix Hybrid Digital Subtraction Angiography (DSA) System: This innovative system integrates advanced imaging with minimally invasive surgical tools, enabling surgeons to perform complex procedures with unparalleled precision and efficiency.
Medtronic Mazury Smart System: This AI-powered platform facilitates remote management of cardiac rhythm management devices, allowing physicians to continuously monitor and adjust treatment plans for improved patient outcomes.
